Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP373063.RArmmVivUVsKrKe1_U4MoA9fWu4Rj0I3B8Rt7NegkNGko130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP373063.RArmmVivUVsKrKe1_U4MoA9fWu4Rj0I3B8Rt7NegkNGko130_assertion type Assertion NP373063.RArmmVivUVsKrKe1_U4MoA9fWu4Rj0I3B8Rt7NegkNGko130_head.
- NP373063.RArmmVivUVsKrKe1_U4MoA9fWu4Rj0I3B8Rt7NegkNGko130_assertion description "[Further investigation is needed to determine the clinical applications of COX-2, VEGF, and EGFR in predicting the long-term outcome of NPC after definitive therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP373063.RArmmVivUVsKrKe1_U4MoA9fWu4Rj0I3B8Rt7NegkNGko130_provenance.
- NP373063.RArmmVivUVsKrKe1_U4MoA9fWu4Rj0I3B8Rt7NegkNGko130_assertion evidence source_evidence_literature NP373063.RArmmVivUVsKrKe1_U4MoA9fWu4Rj0I3B8Rt7NegkNGko130_provenance.
- NP373063.RArmmVivUVsKrKe1_U4MoA9fWu4Rj0I3B8Rt7NegkNGko130_assertion SIO_000772 18758376 NP373063.RArmmVivUVsKrKe1_U4MoA9fWu4Rj0I3B8Rt7NegkNGko130_provenance.
- NP373063.RArmmVivUVsKrKe1_U4MoA9fWu4Rj0I3B8Rt7NegkNGko130_assertion wasDerivedFrom befree-20140225 NP373063.RArmmVivUVsKrKe1_U4MoA9fWu4Rj0I3B8Rt7NegkNGko130_provenance.
- NP373063.RArmmVivUVsKrKe1_U4MoA9fWu4Rj0I3B8Rt7NegkNGko130_assertion wasGeneratedBy ECO_0000203 NP373063.RArmmVivUVsKrKe1_U4MoA9fWu4Rj0I3B8Rt7NegkNGko130_provenance.